Relevant Publications

Plastic and Reconstructive Surgery Global Open, 2019 This analysis compares reconstructive approaches after mastectomy, focusing on cost considerations, patient-reported outcomes, and the challenges clinicians face when evidence across studies is inconsistent or limited. “DIEP reconstruction maybe more cost-effective and yield superior [patient-reported outcomes]. However, poor-quality, bias-ridden studies limit the findings. Adequate reporting of core outcome measures is req

Plastic and Reconstructive Surgery Global Open, 2022 This analysis compares autologous and implant-based breast reconstruction, examining postoperative outcomes and factors associated with recovery and readmission after surgery. “Compared with women who underwent prosthetic reconstructions, studies have shown autologous reconstructions are associated with greater breast satisfaction and increased psychosocial and sexual well-being.” Read the study here.

Microsurgery, 2022 This analysis evaluates nine different approaches to immediate breast reconstruction after mastectomy, comparing clinical outcomes and cost implications from healthcare and societal perspectives to help clinicians and patients consider relative benefits and trade-offs among reconstructive options. “All nine methods of immediate breast reconstruction were considered cost-effective from healthcare/societal perspectives. [Latissimus dorsi] provided the lowest

Annals of Surgical Oncology, 2023 This analysis compares reconstructive approaches for patients who require radiation after mastectomy, examining both outcomes and cost-effectiveness to help guide surgical planning and long-term care decisions. “For patients with [locally advanced breast cancer] who require [post-mastectomy radiation therapy], staged autologous reconstruction is significantly more cost-effective than reconstruction with implants. Despite the decreased morbidi

Plastic and Reconstructive Surgery, 2025 This analysis evaluates the long-term cost-effectiveness of prophylactic mastectomy with autologous reconstruction for individuals with BRCA1/2 mutations, examining how preventive surgery compares with ongoing cancer surveillance and treatment. “Prophylactic mastectomy with autologous reconstruction performed at ages 30, 35 or 40 years, was found to be a cost-effective alternative to breast cancer surveillance and disease treatment in